Arch Therapeutics (ARTH) PT Raised to $3 at Roth Capital
Tweet
Share
E-mailGet Alerts ARTH Hot Sheet
Price: $0.16 --0%
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 19
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 19
Join SI Premium – FREE
Roth Capital analyst David Solomon raised the price target on Arch Therapeutics (OTC: ARTH) to $3.00 (from $2.10) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ooma (OOMA) PT Raised to $24 at Freedom Broker
- China Overseas Land & Investment Ltd. (688:HK) (CAOVF) PT Raised to HK$16.80 at Goldman Sachs
- Yuanta Financial Holding Co Ltd (2885:TT) PT Raised to NT$51.50 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
